Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prodipto Pal

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Science Translational Medicine|February 16, 2022
Ex vivo enzymatic treatment converts blood type A donor lungs into universal blood type lungsAizhou Wang, Rafaela V P Ribeiro, Aadil Ali, et al.
Therapeutic Advances in Medical Oncology|September 26, 2022
Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsyMiguel Garcia-Pardo, Kasia Czarnecka, Jennifer H Law, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2020
EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft modelsSebastiao N Martins-Filho, Jessica Weiss, Nhu-An Pham, et al.
Cancer Treatment and Research Communications|March 12, 2022
Integrating comprehensive genomic sequencing of non-small cell lung cancer into a public healthcare systemKirstin Perdrizet, Tracy L Stockley, Jennifer H Law, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Upfront Next Generation Sequencing in Non-Small Cell Lung CancerShelley Kuang, Andrea S Fung, Kirstin A Perdrizet, et al.
Lung Cancer (Amsterdam, Netherlands)|July 30, 2022
PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLCSally C M Lau, Madhumitha Rabindranath, Jessica Weiss, et al.
JAMA Network Open|July 25, 2023
Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical TrialMiguel García-Pardo, Kasia Czarnecka-Kujawa, Jennifer H Law, et al.
American Journal of Clinical Pathology|May 12, 2021
Comparison of Nuclear Grade, Necrosis, and Histologic Subtype Between Biopsy and Resection in Pleural Malignant Mesothelioma: An International Multi-Institutional AnalysisJefree J Schulte, David B Chapel, Richard Attanoos, et al.
JHLT Open|December 1, 2025
Pathologists' experience and routine practice in high-volume lung transplant centers: An international surveyFiorella Calabrese, David M Hwang, Francesca Lunardi, et al.
Human Molecular Genetics|August 7, 2009
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriersAntonis C Antoniou, Olga M Sinilnikova, Lesley McGuffog, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Science Translational Medicine|February 16, 2022
Ex vivo enzymatic treatment converts blood type A donor lungs into universal blood type lungsAizhou Wang, Rafaela V P Ribeiro, Aadil Ali, et al.
Therapeutic Advances in Medical Oncology|September 26, 2022
Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsyMiguel Garcia-Pardo, Kasia Czarnecka, Jennifer H Law, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2020
EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft modelsSebastiao N Martins-Filho, Jessica Weiss, Nhu-An Pham, et al.
Cancer Treatment and Research Communications|March 12, 2022
Integrating comprehensive genomic sequencing of non-small cell lung cancer into a public healthcare systemKirstin Perdrizet, Tracy L Stockley, Jennifer H Law, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Upfront Next Generation Sequencing in Non-Small Cell Lung CancerShelley Kuang, Andrea S Fung, Kirstin A Perdrizet, et al.
Lung Cancer (Amsterdam, Netherlands)|July 30, 2022
PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLCSally C M Lau, Madhumitha Rabindranath, Jessica Weiss, et al.
JAMA Network Open|July 25, 2023
Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical TrialMiguel García-Pardo, Kasia Czarnecka-Kujawa, Jennifer H Law, et al.
American Journal of Clinical Pathology|May 12, 2021
Comparison of Nuclear Grade, Necrosis, and Histologic Subtype Between Biopsy and Resection in Pleural Malignant Mesothelioma: An International Multi-Institutional AnalysisJefree J Schulte, David B Chapel, Richard Attanoos, et al.
JHLT Open|December 1, 2025
Pathologists' experience and routine practice in high-volume lung transplant centers: An international surveyFiorella Calabrese, David M Hwang, Francesca Lunardi, et al.
Human Molecular Genetics|August 7, 2009
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriersAntonis C Antoniou, Olga M Sinilnikova, Lesley McGuffog, et al.
Pageof 5